Emeryville, United States
BiosPacific, a well-established entity founded in 1989 in the United States, has earned a reputable position in the Biotechnology and Health Care industries. With over three decades of experience, the company specializes in manufacturing and supplying superior-quality antibodies and antigens to the in vitro diagnostics (IVD) market.
The hallmark of BiosPacific's success is its steadfast commitment to offering personalized solutions that effectively meet the stringent requirements of its industrial clientele. The company's offerings include a comprehensive range of monoclonal antibodies, affinity purified polyclonal antibodies, and purified proteins designed to support immunoassay development, from initial feasibility through to full-scale manufacturing.
Although the company has not disclosed any recent investments, its extensive expertise and robust market presence reinforce its potential as a valuable opportunity for investors seeking established ventures in the biotech sector.
